Ingredient

Rasagiline Mesylate

Rasagiline mesylate is a central nervous system active ingredient for alleviating symptoms of Parkinson's disease.

See medicines used for Mental & Nervous System
All medicines
64
Single ingredient
64
Prescription medication
64

MFDS ingredient code M257939

What does it do?

Rasagiline mesylate is a selective monoamine oxidase B (MAO-B) inhibitor used in the treatment of Parkinson's disease. This ingredient is used to alleviate symptoms by reducing the breakdown of dopamine in the brain, thereby increasing dopamine levels. It is primarily included in medications for the purpose of managing symptoms of central nervous system disorders.

Rasagiline mesylate inhibits the enzyme MAO-B, which breaks down dopamine in the brain. As a result, dopamine remains longer, facilitating nerve signal transmission and alleviating the symptoms of Parkinson's disease. It helps improve motor disabilities caused by dopamine deficiency.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Rasagiline mesylate has a higher selectivity compared to other MAO-B inhibitors, resulting in a relatively lower risk of side effects. Additionally, as it acts as an irreversible inhibitor, it has a long duration of action, allowing for effective maintenance with once-daily dosing. These characteristics make it suitable for the treatment of Parkinson's disease.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

64 total

View more

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.